Altria Investors Breathe Easier as Menthol Ban Proposal Is Officially Shelved

Altria gains as FDA formally withdraws menthol cigarette ban proposal, removing a major regulatory threat while maintaining its dividend and earnings guidance.

For income-focused shareholders of Altria, the immediate outlook has brightened considerably. While the upcoming quarterly dividend payment remains a key date on the calendar, a significant regulatory development has provided additional relief. Contrary to recent market speculation about a potential delay, the U.S. Food and Drug Administration (FDA) has not merely postponed but formally withdrawn its proposal for a nationwide menthol cigarette ban.

Regulatory Overhang Lifted

Market chatter had persistently suggested the FDA might push its proposed ban on flavored cigarettes and cigars to this month. In reality, the agency officially retracted the relevant draft rules at the end of January 2025. This action terminates the formal rulemaking process for these specific regulations. Although a future administration could theoretically revisit the issue, the current status represents a clear retreat, removing a substantial regulatory threat from the tobacco giant's core business operations.

Steady Payouts and Confirmed Guidance

The company's management continues to deliver its hallmark consistency regarding shareholder returns. The stock will trade ex-dividend on Wednesday, March 25. Shareholders of record will be entitled to the regular quarterly distribution of $1.06 per share, payable in late April. This dependable income stream supports the equity's valuation. Closing at €55.82 on Friday, Altria's shares have posted a solid year-to-date gain of 14.14 percent.

On the operational front, Altria reaffirms it is tracking its targets. Leadership recently confirmed its full-year outlook, projecting adjusted earnings per share in a range of $5.56 to $5.72. This represents potential growth of up to 5.5 percent compared to the prior year, with the majority of this increase expected in the second half. To counter the structural decline in traditional cigarette volumes, the corporation continues to rely on strategic price increases and the expansion of its smoke-free portfolio, particularly around the "on!" nicotine pouch brand.